全球骨替代品市场 – 行业趋势及 2029 年预测

 骨替代品市场分析及规模

根据疾病预防控制中心的报告，全球髋部骨折的发病率预计在女性中上升 240%，在男性中上升 310%。据估计，全球有 2 亿女性患有骨质疏松症。由于骨密度低，骨骼疾病在老年人中很常见。预计 2016 年 65 岁及以上的美国人数量约为 4600 万，到 2060 年将上升至 9800 万。肌肉骨骼疾病发病率上升和人口老龄化是将为骨替代品市场带来新创新的某些因素。

Data Bridge Market Research 分析，骨替代品市场在 2021 年为 30 亿美元，预计到 2029 年将达到 51.5 亿美元，在 2022 年至 2029 年的预测期内复合年增长率为 7%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

骨替代品市场范围和细分      

Market Definition

A bone graft is an implantable material used to promote bone formation, bone healing, osseous reconstruction, and other procedures. These bone graft materials are used in bone grafting surgical procedures to replace defective or missing bone with these materials (bone graft). Although bone replacement had been practiced with various natural materials, it was rarely successful until the late nineteenth century. These substitutes can be derived from biological products such as demineralized bone matrix, platelet-rich plasma, hydroxyapatite, growth factor adjunction (such as bone morphogenetic protein), or synthetic products such as calcium sulphate, tricalcium phosphate ceramics, bioactive glasses, or polymer-based substitutes. All of these substitutes are not appropriate for every clinical application, and they must be chosen carefully based on their intended use.

Global Bone Substitutes Market Dynamics

Drivers

• Rising increasing incidence of trauma and accident cases

Osteoarthritis is one of the most common articular diseases in people over the age of 65. According to the Centers for Disease Control and Prevention (CDC), an estimated 63 million Americans have arthritis, with that number expected to rise to 78 million by 2040. Furthermore, according to World Population Prospects: The 2019 Revision Data, 1 in 11 people in 2019 were over the age of 65. This figure is expected to rise to one in every six people by 2050.

Furthermore, an increasing incidence of trauma and accident cases worldwide is regarded as one of the major factors likely to boost market demand. According to the National Safety Council, approximately 4.5 million people were severely injured in accidents in 2018. Thus, the above-mentioned factors, the bone substitutes market is expected to witness significant growth over the forecast period.

• Rising number of bone fracture cases

The increasing number of bone fracture cases, as well as the effectiveness of external bone growth stimulators in healing fractures, are driving up product demand. According to a study published in the Archives of Osteoporosis, 2020, fragility fractures accounted for 2.7 million in 2017 in the five largest European Union countries plus Sweden (EU6) and are expected to reach 3.3 million by 2030, a 23% increase from 2017. Furthermore, 14% of the Australian population has osteoporosis, according to a study published in the Orthopaedic Trauma Association International in 2020, and 60,000 hip fractures are expected to occur in Australia by 2050. This reflects the growing global fracture burden. As a result, there is an increasing demand for external bone growth stimulators, which will contribute to the growth of the industry.

Opportunities

• Rise in prevalence of orthopedic diseases

According to the Arthritis Foundation, degenerative joint disease disorders such as osteoarthritis will affect nearly 130 million people worldwide by 2050. The increased prevalence and burden of orthopaedic diseases has resulted in an increase in the patient pool undergoing minimally invasive surgeries worldwide. As a result, bone substitutes are in high demand. The high prevalence of bone marrow transplants and bone cancers increases the demand for bone substitutes.

Restraints/Challenges

• Limited medical reimbursement

Limited medical reimbursement for bone stimulation products and high treatment costs associated with BMP and PRP products will obstruct market growth, while side effects associated with BMP-based orthopaedic treatment will further challenge market growth during the forecast period.

This bone substitutes market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone substitutes market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Bone Substitutes Market

The COVID-19 had a negative impact on the bone substitutes market. Companies are facing a setback lockdown, which has caused disruptions in supply chain activities around the world. The worldwide implementation of lockdown restrictions has resulted in a decrease in patient visits. However, the situation is projected to improve as governments around the world begin to ease guidelines for resuming business activities. Furthermore, the demand for bone substitutes is expected to rise as elective surgeries and procedures resume in the near future.

Recent developments

• In November 2019, Stryker announced a definitive agreement to acquire Wright Medical Group. N.V. Wright Medical, which was founded in 1950, is a global medical device company that specialises in extremities and biologics.

Global Bone Substitutes Market Scope

The bone substitutes market is segmented on the basis of product, end user, and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Autotrans plantation
• Xenotrans plantation
• Allograft
• Demineralized Bone Matrix
• Others
• Synthetic
• Ceramics
• HAP
• β-TCP
• α-TCP
• Bi-phasic Calcium Phosphates (BCP)
• Others
• Composite
• Polymer
• Bone morphogenetic

End User

• Hospitals
• Specialty Clinics

 Application

• Spinal Fusion
• 关节重建
• 足部和踝部
• 其他的

骨替代品市场区域分析/见解

对骨替代品市场进行了分析，并按国家、产品、最终用户和应用提供了市场规模洞察和趋势，如上所述。

骨替代品市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

北美占据骨骼生长刺激器市场的主导地位，因为该地区骨质疏松症或脊椎骨折的发病率很高，各公司正在增加电动骨骼生长刺激器的供应，这种刺激器在脊柱融合手术后很有用。

由于该地区道路交通事故和创伤案件数量不断增加，预计亚太地区在 2022 年至 2029 年的预测期内将以最高增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

骨替代品市场还为您提供每个国家/地区资本设备医疗支出增长、骨替代品市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对骨替代品市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和骨替代品市场份额分析

骨替代品市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对骨替代品市场的关注有关。

骨替代品市场的一些主要参与者包括：

• Zimmer Biomet（美国）
• Bioventus（美国）
• Synergy Orthopedics（美国）
• 伊藤株式会社（日本）
• 波士顿科学公司 (美国)
• BTL（加拿大）
• Cyber​​onics, Inc.（美国）
• DJO LLC（美国）
• 美敦力（爱尔兰）
• Nevro Corp（美国）
• NeuroMetrix, Inc（美国）
• 雅培（美国）
• Uroplasty Inc（美国）
• Cogentix Medical（美国）
• Aleva Neurotherapeutics（瑞士）
• NeuroPace Inc（美国）
• AxioBionics（美国）
• Beurer GmbH（德国）
• 欧姆龙医疗有限公司（日本）
• RS Medical（日本）
• 史赛克（美国）

SKU-56384